MorphoSys gains enterprise supply chain agility in only eight weeks

MorphoSys gains enterprise supply chain agility in only eight weeks

London, UK, 19th July 2021 – Today, Kinaxis is pleased to welcome MorphoSys into its community of supply chain innovators. The fast-growing U.S. and European biotech company joins an expanding list of businesses who have gone live with advanced planning in less than 12 weeks thanks to RapidStart, Kinaxis’ revolutionary enterprise deployment methodology.

Last year MorphoSys received accelerated U.S. approval for its first oncology medicine, a combination treatment for a certain type of blood cancer. With a new product, MorphoSys has many moving elements when planning supply and demand. It had been running what-if scenarios in Excel which was time consuming, error prone and not sustainable.

MorphoSys selected Kinaxis for demand planning, supply planning and inventory management to better synchronise supply and demand for its newly-introduced cancer therapy. Leveraging the Kinaxis RapidResponse® platform and concurrent planning, MorphoSys gained agility and transparency across its supply chain to drive smarter, more timely decision making. The first phase of the MorphoSys deployment was completed in just eight weeks leveraging the RapidStart accelerated go-live process.

“By spending so much time focusing on the accuracy of the data, we were losing sight of the information that the data was telling us,” said Ann Merchant, Head of Global Supply Chain, MorphoSys. “At the same time, as we were introducing a new product and developing our process, we knew we needed a tool that would allow us to manage complexity and provide the agility to make changes instantly. Kinaxis demonstrated a clear understanding of our business, and willingness to be flexible, and a solution that sees us realising benefits in a matter of weeks.”

With Kinaxis, MorphoSys can run what-if scenarios to instantly see what the impact of changes to its supply and demand will be when unavoidable adjustments to the plan occur. In the future, MorphoSys will focus on inventory optimisation and monitor inventory levels more quickly. The company also plans to integrate the available output with other internal departments like finance to better align financial planning.

With the pace of business and rate of disruptions only accelerating, companies want the fastest time to successful enterprise go-live as possible. Kinaxis has innovated its processes to offer an unmatched RapidStart deployment methodology that provides a seamless path to expand both capabilities and processes over time—without disrupting the business.

The entire Kinaxis team is thrilled to be working with MorphoSys to deploy RapidResponse in only eight weeks to make its supply planning more efficient. We share the MorphoSys’ focus on innovation and agility and look forward to working with them to streamline their supply chain operations and ensure that they get their medications out to the people that need them as quickly as possible.